{'52WeekChange': 0.19362938,
 'SandP52WeekChange': 0.0644362,
 'address1': '9924 West 74th Street',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 47.74,
 'askSize': 900,
 'averageDailyVolume10Day': 62712,
 'averageVolume': 69704,
 'averageVolume10days': 62712,
 'beta': 0.974229,
 'beta3Year': None,
 'bid': 33.28,
 'bidSize': 1200,
 'bookValue': 9.182,
 'category': None,
 'circulatingSupply': None,
 'city': 'Eden Prairie',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 48.64,
 'dayLow': 45.377,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': 0.158,
 'enterpriseToEbitda': 45.825,
 'enterpriseToRevenue': 5.989,
 'enterpriseValue': 602466496,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '952-500-7001',
 'fiftyDayAverage': 42.935143,
 'fiftyTwoWeekHigh': 49,
 'fiftyTwoWeekLow': 22.06,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 10374582,
 'forwardEps': 0.17,
 'forwardPE': 279.94116,
 'fromCurrency': None,
 'fullTimeEmployees': 369,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.03336,
 'heldPercentInstitutions': 0.92807996,
 'industry': 'Diagnostics & Research',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1569801600,
 'lastMarket': None,
 'lastSplitDate': 976147200,
 'lastSplitFactor': '2:1',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/surmodics.com',
 'longBusinessSummary': 'Surmodics, Inc., together with its subsidiaries, '
                        'provides medical devices and in vitro diagnostic '
                        'technologies to the healthcare industry in the United '
                        'States and internationally. The company operates '
                        'through two segments, Medical Device and In Vitro '
                        'Diagnostics. The Medical Device segment designs, '
                        'develops, and manufactures interventional medical '
                        'devices primarily for the peripheral vascular market; '
                        'and offers surface modification coating technologies '
                        'to enhance access, deliverability, and predictable '
                        'deployment of medical devices, as well as drug '
                        'delivery coating technologies to provide '
                        'site-specific drug delivery from the surface of a '
                        'medical device for the coronary, peripheral, '
                        'neuro-vascular, urology, and other markets. The Vitro '
                        'Diagnostics segment provides stabilization products, '
                        'substrates, antigens, and surface coatings to '
                        'diagnostics customers; and manufactures or sells '
                        'components for in vitro diagnostic immunoassay and '
                        'molecular tests, as well as surface coatings to the '
                        'diagnostic, biomedical research, and life science '
                        'markets. Surmodics, Inc. was founded in 1979 and is '
                        'headquartered in Eden Prairie, Minnesota.',
 'longName': 'Surmodics, Inc.',
 'market': 'us_market',
 'marketCap': 647623744,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_381362',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': 6630000,
 'nextFiscalYearEnd': 1632960000,
 'open': 48.05,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': 22.91,
 'phone': '952-500-7000',
 'previousClose': 48.11,
 'priceHint': 2,
 'priceToBook': 5.1829667,
 'priceToSalesTrailing12Months': 6.43774,
 'profitMargins': 0.065910004,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 48.64,
 'regularMarketDayLow': 45.377,
 'regularMarketOpen': 48.05,
 'regularMarketPreviousClose': 48.11,
 'regularMarketPrice': 48.05,
 'regularMarketVolume': 51637,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 13608400,
 'sharesPercentSharesOut': 0.028499998,
 'sharesShort': 387648,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 397162,
 'shortName': 'Surmodics, Inc.',
 'shortPercentOfFloat': 0.0352,
 'shortRatio': 4.9,
 'startDate': None,
 'state': 'MN',
 'strikePrice': None,
 'symbol': 'SRDX',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': 0.48,
 'trailingPE': 99.145836,
 'twoHundredDayAverage': 37.73712,
 'volume': 51637,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.surmodics.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '55344'}